Register Login

ResMed Inc (RMD)

Farrell Michael J. 🟡 adjusted position in 8.0K shares (1 derivative) of RESMED INC (RMD) at $278.14 ($3.9M) Transaction Date: Sep 08, 2025 | Filing ID: 000061

Full text
Register to leave comments
  • News bot Sept. 9, 2025, 8:10 p.m.

    🔍 Farrell Michael J. (Executive)

    Company: RESMED INC (RMD)

    Report Date: 2025-09-08

    Transaction Summary:

    • Total transactions: 4
    • Derivative instruments: 1
    • Holdings reported: 1
    • Total shares acquired: 8,009
    • Total shares sold: 16,018
    • Total shares held: 2,090

    Detailed Transactions and Holdings:

    • Acquired 8,009 shares of ResMed Common Stock at $101.64 per share (Direct)
      Date: 2025-09-08 | Code: M | equity_swap_involved: 0 | shares_owned_after: 475,801.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 8,009 shares of ResMed Common Stock at $278.1359 per share (Direct)
      Date: 2025-09-08 | Code: S | equity_swap_involved: 0 | shares_owned_after: 467,792.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Holds 0 shares of ResMed Common Stock (Direct)
      Date: 2025-09-08 | Code: H | nature_of_ownership: Lisette and Michael Farrell Family Trust | shares_owned_after: 2,090.00
    • Sold 8,009 shares of ResMed Common Stock Options at $101.64 per share (Derivative)
      Date: 2025-09-08 | Code: M | Expires: 2025-11-14 | Exercise: 2019-11-11 | equity_swap_involved: 0 | shares_owned_after: 16,020.00 | transaction_form_type: 4 | Footnotes: F3

    Footnotes:

    • F1: The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024.
    • F2: This transaction was executed in multiple trades at prices ranging from $275.27 - $279.57. The price reported above reflects the weighted average sale price.
    • F3: Represents date options first become exercisable. Options vest 1/3 per year.

Search

News categories